Osten Enzyme India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.69 M
- Company Age 30 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.48 Cr
- Revenue Growth -35.76%
- Profit Growth 121.49%
- Ebitda 189.18%
- Net Worth 5.61%
- Total Assets -1.30%
About Osten Enzyme India
Osten Enzyme India Private Limited (OEIPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 April 1994 and has a history of 30 years and ten months. Its registered office is in Madras 600 034, Tamil Nadu.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.69 M.
The company currently has active open charges totaling ₹16.48 Cr.
Kannan Geetha and Kannan Hirokumar serve as directors at the Company.
Company Details
- Location Madras 600 034, Tamil Nadu
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U52599TN1994PTC027239
- Company No.
027239
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Osten Enzyme India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kannan Geetha  | Director | 01-Mar-2023 | Current |
| Kannan Hirokumar | Director | 02-Nov-1998 | Current |
Financial Performance of Osten Enzyme India.
Osten Enzyme India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.76% decrease. The company also saw a substantial improvement in profitability, with a 121.49% increase in profit. The company's net worth moved up by a moderate rise of 5.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Osten Enzyme India?
Unlock access to Osten Enzyme India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kjk Polydiamonds International Private LimitedKannan Geetha and Kannan Hirokumar are mutual person
Charges (Loans)
₹16.48 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 16.48 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jan 2006 | State Bank Of India | ₹16.48 Cr | Open |
How Many Employees Work at Osten Enzyme India?
Osten Enzyme India has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Osten Enzyme India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osten Enzyme India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
